Eli Lilly has an AI chief, telehealth’s DEA troubles, and FDA’s thinking on AI in clinical trials

STAT October 10, 2024
Mario Aguilar

Lilly appoints Chief AI Officer

Drug giant Eli Lilly announced Thomas Fuchs as its first chief AI officer. Previously, Fuchs was director of the Hasso Plattner Institute for Digital Health at Mount Sinai in New York where he helped lead work on computational pathology. He’s also the founder of several companies including cancer diagnostic startup Paige AI.

Earlier this week we wrote about Eli Lilly’s latest AI drug development deal.

Telehealth companies describe frustration with DEA

Telehealth companies that ramped up prescribing of controlled substances during the pandemic are in a state of frustration as flexibilities that allowed them to grow their businesses are set to expire. It’s been over a year since the Drug Enforcement Administration last extended the...

Today's Sponsors

Today's Sponsor